Verona Pharma

+$0.02 (+0.45%) Today
-$0.06 (-1.34%) As of 8:00 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Verona Pharma and other ETFs, options, and stocks.

About VRNA

Verona Pharma Plc operates as a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for the treatment of respiratory diseases. Its lead product candidate, ensifentrine, has the potential to be the first therapy for the treatment of respiratory diseases that combines bronchodilator and anti-inflammatory activities in one compound.

CEO
David S. Zaccardelli
Employees
26
Headquarters
London, Greater London
Founded
2005

VRNA Key Statistics

Market cap
270.45M
Price-Earnings ratio
—
Dividend yield
—
Average volume
157.83K
High today
$4.50
Low today
$4.29
Open price
$4.49
Volume
30.42K
52 Week high
$7.87
52 Week low
$3.41

VRNA Earnings

-$0.48
-$0.27
-$0.05
$0.16
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure